Siglec‐G Suppresses CD8+ T Cells Responses through Metabolic Rewiring and Can be Targeted to Enhance Tumor Immunotherapy

Abstract CD8+ T cells play a critical role in cancer immune‐surveillance and pathogen elimination. However, their effector function can be severely impaired by inhibitory receptors such as programmed death‐1 (PD‐1) and T cell immunoglobulin domain and mucin domain‐3 (Tim‐3). Here Siglec‐G is identif...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Shenhui Yin, Chunzhen Li, Xin Shen, Guanyu Yu, Likun Cui, Yunyang Wu, Yixian He, Shu Yu, Jie Chen, Shaoteng Lu, Guifang Qiu, Mengqi Song, Cheng Qian, Zui Zou, Yizhi Yu, Sheng Xu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2024-12-01
coleção:	Advanced Science
Assuntos:	CD8+ T cells metabolic rewiring Siglec‐G tumor immunotherapy
Acesso em linha:	https://doi.org/10.1002/advs.202403438
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!